ASP Isotopes Inc. (ASPI)
NASDAQ: ASPI · IEX Real-Time Price · USD
3.340
+0.140 (4.37%)
Apr 24, 2024, 4:00 PM EDT - Market closed
ASP Isotopes Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ASP Isotopes stock has a target of 5.50, which predicts an increase of 64.67% from the current stock price of 3.34.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for ASP Isotopes is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.25 → $5.5 | Strong Buy | Maintains | $5.25 → $5.5 | +64.67% | Apr 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.25 → $5.25 | Strong Buy | Maintains | $3.25 → $5.25 | +57.19% | Feb 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | -2.69% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
11.93M
from 433.03K
Increased by 2,655.95%
Revenue Next Year
n/a
from 11.93M
EPS This Year
0.07
from -0.49
EPS Next Year
n/a
from 0.07
Revenue Forecast
Revenue | 2024 |
---|---|
High | 12.3M |
Avg | 11.9M |
Low | 11.5M |
Revenue Growth
Revenue Growth | 2024 |
---|---|
High | 2,737.0% |
Avg | 2,656.0% |
Low | 2,547.9% |
EPS Forecast
EPS | 2024 |
---|---|
High | 0.07 |
Avg | 0.07 |
Low | 0.07 |
EPS Growth
EPS Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.